Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis

The Lancet Infectious Diseases

Volumn 13, Issue 1, 2013, Pages 77-88

  Ralph, Anna R ^a,b,c   Lucas, Robyn M ^d   Norval, Mary ^e  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BLACKTOWN HOSPITAL   (Australia)

^d The Australian National University   (Australia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIMYCOBACTERIAL AGENT; VITAMIN D;

ADAPTIVE IMMUNITY; CLINICAL PRACTICE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HYPOTHESIS; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOLAR ULTRAVIOLET RADIATION; TUBERCULOSIS; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTI-BACTERIAL AGENTS; DIETARY SUPPLEMENTS; HUMANS; TUBERCULOSIS; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84871096851     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70275-X     Document Type: Review

References (144)

1. Global tuberculosis report 2012 2012, WHO, World Health Organization, Geneva, (accessed Nov 1, 2012). http://www.who.int/tb/publications/global_report/gtbr12_main.pdf.
2. Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol 2012, 77:26-35.
3. Grant CC, Wall CR, Crengle S, Scragg R Vitamin D deficiency in early childhood: prevalent in the sunny South Pacific. Public Health Nutr 2009, 12:1893-1901.
4. Holick MF The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 2008, 29:361-368.
5. Marwaha RK, Tandon N, Reddy DR, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005, 82:477-482.
6. Flynn JL, Chan J What's good for the host is good for the bug. Trends Microbiol 2005, 13:98-102.
7. Flynn JL, Chan J Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 2003, 15:450-455.
8. Harries AD, Dye C Tuberculosis. Ann Trop Med Parasitol 2006, 100:415-431.
9. The global plan to stop TB 2011-2015. Transforming the fight: towards elimination of tuberculosis 2011 2011, WHO and Stop TB Partnership, World Health Organization, Geneva.
10. Barry CE, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009, 7:845-855.
11. Lin PL, Flynn JL Understanding latent tuberculosis: a moving target. J Immunol 2010, 185:15-22.
12. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
13. Pai M, Zwerling A, Menzies D Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
14. Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009, 360:2397-2405.
15. Diacon AH, Dawson R, von Groote-Bidlingmaier F, et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet 2012, 380:986-993.
16. Gler MT, Skripconoka V, Sanchez-Garavito E, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012, 366:2151-2160.
17. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011, 365:2155-2166.
18. Onyebujoh P, Rodriguez W, Mwaba P Priorities in tuberculosis research. Lancet 2006, 367:940-942.
19. Reljic R IFN-gamma therapy of tuberculosis and related infections. J Interferon Cytokine Res 2007, 27:353-364.
20. Ralph AP, Kelly PM, Anstey NM L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol 2008, 16:336-344.
21. Prasad K, Singh MB Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008, 1:CD002244.
22. Skerry C, Harper J, Klunk M, Bishai WR, Jain SK Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One 2012, 7:e39680.
23. Berer A, Stockl J, Majdic O, et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000, 28:575-583.
24. Kripke ML, Fisher MS Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst 1976, 57:211-215.
25. Norval M, Halliday GM The consequences of UV-induced immunosuppression for human health. Photochem Photobiol 2011, 87:965-977.
26. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
27. Fabri M, Stenger S, Shin DM, et al. Vitamin D is required for IFN-{gamma}--mediated antimicrobial activity of human macrophages. Sci Transl Med 2011, 3:104ra102.
28. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.
29. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250.
30. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176:208-213.
31. Nnoaham KE, Clarke A Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37:113-119.
32. Roelandts R The history of phototherapy: something new under the sun?. J Am Acad Dermatol 2002, 46:926-930.
33. Grad R Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm Hist 2004, 46:106-120.
34. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008, 46:443-446.
35. Davies P Vitamin D and tuberculosis. Am J Respir Crit Care Med 2010, 181:94.
36. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012, 95:1357-1364.
37. Norman AW, Mizwicki MT, Norman DP Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004, 3:27-41.
38. Bruce D, Ooi JH, Yu S, Cantorna MT Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 2010, 235:921-927.
39. Ren S, Nguyen L, Wu S, Encinas C, Adams JS, Hewison M Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem 2005, 280:20604-20611.
40. Lucas R, McMichael T, Smith W, Armstrong B Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation 2006, World Health Organization, Geneva.
41. Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol 2010, 130:546-553.
42. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
43. Lai JK, Lucas RM, Clements MS, Harrison SL, Banks E Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010, 54:1062-1071.
44. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004, 89:3152-3157.
45. Hollis BW Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 2004, 89:3149-3151.
46. Lai JK, Lucas RM, Banks E, Ponsonby AL Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 2012, 42:43-50.
47. Maunsell Z, Wright DJ, Rainbow SJ Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005, 51:1683-1690.
48. Vesper HW, Sempos CT, for the Vitamin D Standardization Program. Vitamin D Standardization Program. Poster 07211. Centers for Disease Control and Prevention, Atlanta, Georgia and National Institutes of Health, Bethesda, Maryland. American Association for Clinical Chemistry Annual Meeting; Atlanta (GA, USA); July 24-28, 2011.
49. Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's principles and practices of internal medicine 1998, McGraw-Hill, Singapore. 14th edn.
50. Diamond TH, Eisman JA, Mason RS, et al. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005, 182:281-285. Working Group of Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia.
51. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
52. Hollis BW Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135:317-322.
53. Holick MF Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
54. Dietary reference intakes for calcium and vitamin D 2011, Institute of Medicine (US) committee to review dietary reference intakes for vitamin D and calcium, National Academies Press, Washington DC. A.C. Ross, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.).
55. Pearce SH, Cheetham TD Diagnosis and management of vitamin D deficiency. BMJ 2010, 340:b5664.
56. Vitamin D deficiency: a global epidemic Vitamin D Council, (accessed Oct 18, 2011). http://www.vitamindcouncil.org/about-vitamin-d/vitamin-d-deficiency/.
57. Wagner CL, Greer FR Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008, 122:1142-1152.
58. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007, 86:1376-1383.
59. Banda R, Mhemedi B, Allain TJ Prevalence of vitamin D deficiency in adult tuberculosis patients at a central hospital in Malawi. Int J Tuberc Lung Dis 2011, 15:408-410.
60. Ginde AA, Liu MC, Camargo CA Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
61. Vieth R Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842-856.
62. Stamp TC Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc Nutr Soc 1975, 34:119-130.
63. Adams JS, Clemens TL, Parrish JA, Holick MF Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med 1982, 306:722-725.
64. Davie MW, Lawson DE, Emberson C, Barnes JL, Roberts GE, Barnes ND Vitamin D from skin: contribution to vitamin D status compared with oral vitamin D in normal and anticonvulsant-treated subjects. Clin Sci 1982, 63:461-472.
65. Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 1998, 13:1238-1242.
66. Diffey BL Is casual exposure to summer sunlight effective at maintaining adequate vitamin D status?. Photodermatol Photoimmunol Photomed 2010, 26:172-176.
67. Rhodes LE, Webb AR, Fraser HI, et al. Recommended summer sunlight exposure levels can produce sufficient (> or =20 ng ml(-1)) but not the proposed optimal (> or =32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol 2010, 130:1411-1418.
68. Webb AR, Kift R, Durkin MT, et al. The role of sunlight exposure in determining the vitamin D status of the U.K. white adult population. Br J Dermatol 2010, 163:1050-1055.
69. Farrar MD, Kift R, Felton SJ, et al. Recommended summer sunlight exposure amounts fail to produce sufficient vitamin D status in UK adults of south Asian origin. Am J Clin Nutr 2011, 94:1219-1224.
70. Vieth R How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009, 29:3675-3684.
71. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822.
72. Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997, 12:915-921.
73. Colin EM, Weel AE, Uitterlinden AG, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 2000, 52:211-216.
74. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000, 14:401-420.
75. Gao L, Tao Y, Zhang L, Jin Q Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010, 14:15-23.
76. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
77. Roth DE, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004, 190:920-927.
78. Babb C, van der Merwe L, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb) 2007, 87:295-302.
79. Selvaraj P, Prabhu Anand S, Harishankar M, Alagarasu K Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 2009, 29:470-478.
80. Papiha SS, White I, Roberts DF Some genetic implications of isoelectric focusing of human red cell phosphoglucomutase (PGM1) and serum protein group specific component (Gc): genetic diversity in the populations of Himachal Pradesh, India. Hum Genet 1983, 63:67-72.
81. Martineau AR, Leandro AC, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 2010, 35:1106-1112.
82. van Etten E, Mathieu C Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
83. Hewison M Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011, 7:337-345.
84. Gynther P, Toropainen S, Matilainen JM, Seuter S, Carlberg C, Vaisanen S Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim Biophys Acta 2011, 1813:810-818.
85. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
86. Hmama Z, Sendide K, Talal A, Garcia R, Dobos K, Reiner NE Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci 2004, 117:2131-2140.
87. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001, 98:6800-6805.
88. Cantorna MT, Zhao J, Yang L Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc 2012, 71:62-66.
89. Coussens A, Timms PM, Boucher BJ, et al. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009, 127:539-548.
90. Yamamoto N, Homma S, Millman I Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 1991, 147:273-280.
91. Martineau AR Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc 2012, 71:84-89.
92. Khoo AL, Chai LY, Koenen HJ, et al. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011, 55:294-300.
93. Yesudian PD, Berry JL, Wiles S, et al. The effect of ultraviolet B-induced vitamin D levels on host resistance to Mycobacterium tuberculosis: a pilot study in immigrant Asian adults living in the United Kingdom. Photodermatol Photoimmunol Photomed 2008, 24:97-98.
94. Hart PH, Gorman S, Finlay-Jones JJ Modulation of the immune system by UV radiation: more than just the effects of vitamin D?. Nat Rev Immunol 2011, 11:584-596.
95. Schwarz T, Schwarz A Molecular mechanisms of ultraviolet radiation-induced immunosuppression. Eur J Cell Biol 2011, 90:560-564.
96. Fukunaga A, Khaskhely NM, Ma Y, et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J Immunol 2010, 185:4633-4640.
97. Glaser R, Navid F, Schuller W, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 2009, 123:1117-1123.
98. Kuritzky LA, Finlay-Jones JJ, Hart PH The controversial role of vitamin D in the skin: immunosuppression vs. photoprotection. Clin Exp Dermatol 2008, 33:167-170.
99. Dixon KM, Norman AW, Sequeira VB, et al. 1alpha,25(OH)-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis. Cancer Prev Res (Phila) 2011, 4:1485-1494.
100. Fares A Seasonality of tuberculosis. J Glob Infect Dis 2011, 3:46-55.
101. Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 2011, 108:19013-19017.
102. Parrinello CM, Crossa A, Harris TG Seasonality of tuberculosis in New York City, 1990-2007. Int J Tuberc Lung Dis 2012, 16:32-37.
103. Jeevan A, Sharma AK, McMurray DN Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs. Tuberculosis (Edinb) 2009, 89:431-438.
104. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271:698-702.
105. Fine PE Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
106. Damian DL, Halliday GM, Taylor CA, Barnetson RS Ultraviolet radiation induced suppression of Mantoux reactions in humans. J Invest Dermatol 1998, 110:824-827.
107. Seckmeyer G, Klingebiel M, Riechelmann S, et al. A critical assessment of two types of personal UV dosimeters. Photochem Photobiol 2012, 88:215-222.
108. Deluca HF Historical overview of vitamin D. Vitamin D 2011, Elsevier, London. 3rd edn. D. Feldman, J.W. Pike, J.S. Adams (Eds.).
109. Windaus A, Linsert O, Luttringhaus A, Weidlinch G über das krystallistierte Vitamin D2. Justis Liebigs Ann Chem 1932, 492:226-231.
110. Dowling GB, Prosser Thomas EW Treatment of lupus vulgaris with calciferol. Lancet 1946, 1:919-922.
111. Lavender TW, Martineau AR, Quinton R, Schwab U Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D. Int J Tuberc Lung Dis 2012, 16:140.
112. Ellman P, Anderson KH Calciferol in tuberculous peritonitis with disseminated tuberculosis. BMJ 1948, 1:394.
113. Moller KI, Kongshoj B, Philipsen PA, Thomsen VO, Wulf HC How Finsen's light cured lupus vulgaris. Photodermatol Photoimmunol Photomed 2005, 21:118-124.
114. Escombe AR, Moore DA, Gilman RH, et al. Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med 2009, 6:e43.
115. Howson CR Heliotherapy in pulmonary tuberculosis-its possibilities and dangers. Cal West Med 1928, 29:25-30.
116. Davies PD A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985, 66:301-306.
117. Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985, 66:187-191.
118. Davies PD, Church HA, Brown RC, Woodhead JS Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987, 71:341-344.
119. Davies PD, Church HA, Bovornkitti S, Charumilind A, Byrachandra S Altered vitamin D homeostasis in tuberculosis. Int Med Thailand 1988, 4:45-47.
120. Chan TY, Poon P, Pang J, et al. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg 1994, 97:26-30.
121. Sasidharan PK, Rajeev E, Vijayakumari V Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002, 50:554-558.
122. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007, 62:1003-1007.
123. Friis H, Range N, Pedersen ML, et al. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr 2008, 138:2474-2480.
124. Tostmann A, Wielders JP, Kibiki GS, Verhoef H, Boeree MJ, van der Ven AJ Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. Int J Tuberc Lung Dis 2010, 14:1147-1152.
125. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010, 104:1487-1491.
126. Nansera D, Graziano FM, Friedman DJ, Bobbs MK, Jones AN, Hansen KE Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 2011, 15:1522-1528.
127. Talat N, Perry S, Parsonnet J, Dawood G, Hussain R Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 2010, 16:853-855.
128. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005, 50:432-437.
129. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis - a double-blind randomized placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.
130. Conesa-Botella A, Meintjes G, Coussens AK, et al. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis 2012, 55:1004-1011.
131. Clements MR, Johnson L, Fraser DR A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987, 325:62-65.
132. Khadilkar A, Das G, Sayyad M, et al. Low calcium intake and hypovitaminosis D in adolescent girls. Arch Dis Child 2007, 92:1045.
133. Selvaraj P, Prabhu Anand S, Harishankar M, Alagarasu K Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 2009, 29:470-478.
134. Glossmann HH Origin of 7-dehydrocholesterol (provitamin D) in the skin. J Invest Dermatol 2010, 130:2139-2141.
135. Gupta RP, Hollis BW, Patel SB, Patrick KS, Bell NH CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 2004, 19:680-688.
136. Brodie MJ, Boobis AR, Hillyard CJ, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982, 32:525-530.
137. Dahl B, Schiodt FV, Ott P, et al. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 2003, 31:152-156.
138. White P, Cooke N The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000, 11:320-327.
139. Christopoulos AI, Diamantopoulos AA, Dimopoulos PA, Goumenos DS, Barbalias GA Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial. BMC Nephrol 2009, 10:36.
140. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007, 103:793-798.
141. Nursyam EW, Amin Z, Rumende CM The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38:3-5.
142. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012, 109:15449-15454.
143. Lai JK, Lucas RM, Clements MS, Roddam AW, Banks E Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health 2010, 10:331.
144. Lappe JM, Heaney RP Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 2012, 4:1-6.